{"Abbreviation":"","Aliases":["CARFENTANIL","Carfentanila","Carfentanilum","Wildnil","Carfentanil [INN]","4-carbomethoxyfentanyl","carfentanilo","Methyl 1-phenylethyl-4-(N-phenylpropionamido)isonipecotate","LA9DTA2L8F","(4-carbomethoxy fentanyl)"],"CAS":"59708-52-0","ChEBI":"CHEBI:61084","ChEMBL":"CHEMBL290429","ChemicalClasses":["piperidine"],"Chirality":"achiral","DEA no":9743,"Dosing Info":[],"Drug Indication":"Carfentanil is similar (but more potent) to the opioid analgesic fentanyl. It is used as a tranquilizer for large animals.","DrugClasses":["opioid"],"European Community (EC) Number":"955-107-3","IUPACName":"methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate","InChI":"InChI=1S/C24H30N2O3/c1-3-22(27)26(21-12-8-5-9-13-21)24(23(28)29-2)15-18-25(19-16-24)17-14-20-10-6-4-7-11-20/h4-13H,3,14-19H2,1-2H3","InChIKey":"YDSDEBIZUNNPOB-UHFFFAOYSA-N","MeSH Pharmacological Classification":"Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)","MolecularFormula":"C\u003csub\u003e24\u003c/sub\u003eH\u003csub\u003e30\u003c/sub\u003eN\u003csub\u003e2\u003c/sub\u003eO\u003csub\u003e3\u003c/sub\u003e","MolecularWeight":"394.5 g/mol","Pharmacodynamics":"Carfentanil acts primarily on the mu (some kappa and delta) opioid receptors as an agonist. It will induce similar effects of analgesia as other opioids, however, due to its potency, it will also induce strong side effects such as sedation. Consequently, that is why it is used as a tranquilizer for large animals.  Carfentanil interacts predominately with the opioid mu-receptor. These mu-binding sites are discretely distributed in the brain, spinal cord, and other tissues. It exerts its principal pharmacologic effects on the central nervous system. Its primary actions of therapeutic value are analgesia and sedation. Carfentanil also depresses the respiratory centers, depresses the cough reflex, and constricts the pupils.","PubChemId":62156,"Record Description":["Carfentanil is a monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of methyl 4-anilino-1-(2-phenylethyl)piperidine-4-carboxylate with propanoic acid. It has a role as a mu-opioid receptor agonist, an opioid analgesic and a tranquilizing drug. It is a member of piperidines, a methyl ester, a tertiary amino compound and a tertiary carboxamide.","Carfentanil is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence. It is a Opiates substance.","Carfentanil or carfentanyl (Wildnil) is an analogue of the popular synthetic opioid analgesic fentanyl, and is one of the most potent opioids known (also the most potent opioid used commercially). Carfentanil was first synthesized in 1974 by a team of chemists at Janssen Pharmaceutica which included Paul Janssen. It has a quantitative potency approximately 10,000 times that of morphine and 100 times that of fentanyl, with activity in humans starting at about 1 microgram. It is marketed under the trade name Wildnil as a general anaesthetic agent for large animals. Carfentanil is intended for large-animal use only as its extreme potency makes it inappropriate for use in humans. Currently sufentanil, approximately 10–20 times less potent (500 to 1000 times the efficacy of morphine per weight) than carfentanil, is the maximum strength fentanyl analog for use in humans.","CARFENTANIL is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.","Carfentanil is a monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of methyl 4-anilino-1-(2-phenylethyl)piperidine-4-carboxylate with propanoic acid. It has a role as a mu-opioid receptor agonist, an opioid analgesic and a tranquilizing drug. It is a member of piperidines, a methyl ester, a tertiary amino compound and a tertiary carboxamide.","Side effects of carfentanil are similar to those of fentanyl, which include itching, nausea and respiratory depression, which can be life-threatening. Fentanyl analogs have killed hundreds of people throughout Europe and the former Soviet republics since the most recent resurgence in use began in Estonia in the early 2000s, and novel derivatives continue to appear. Carfentanil is classified as Schedule II under the Controlled Substances Act in the United States with a DEA ACSCN of 9743 and a 2016 annual aggregate manufacturing quota of 19 grams. In 2016, carfentanil was identified as an additive in heroin sold in Ohio, leading to a spike in the number of overdose cases.","WIKIPEDIA|FENTANYL ANALOGUES"],"References":[{"name":"Wikipedia","url":"https://en.wikipedia.org/wiki/Carfentanil"},{"name":"Wikidata","url":"https://www.wikidata.org/wiki/Q423386"},{"name":"DrugBank","url":"https://go.drugbank.com/drugs/DB01535"},{"name":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/62156"},{"name":"ChemSpider","url":"https://www.chemspider.com/Chemical-Structure.55986.html"},{"name":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL290429"},{"name":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:61084"},{"name":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=59708-52-0"},{"name":"KEGG","url":"https://www.kegg.jp/entry/D07620"},{"name":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/LA9DTA2L8F"},{"name":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID40208427"}],"SMILES":"CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CC=C3)C(=O)OC","Salts":["citrate"],"StructureBase64":"<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" height="94.66mm" version="1.2" viewBox="0 0 156.835 94.66" width="156.835mm">
      
    <desc>Generated by the Chemistry Development Kit (http://github.com/cdk)</desc>
      
    <g fill="#FF0D0D" stroke="#000000" stroke-linecap="round" stroke-linejoin="round" stroke-width=".7">
            
        <rect fill="#FFFFFF" height="95.0" stroke="none" width="157.0" x=".0" y=".0"/>
            
        <g class="mol" id="mol1">
                  
            <line class="bond" id="mol1bnd1" x1="155.826" x2="141.506" y1="47.948" y2="53.162"/>
                  
            <line class="bond" id="mol1bnd2" x1="141.506" x2="129.83" y1="53.162" y2="43.367"/>
                  
            <g class="bond" id="mol1bnd3">
                        
                <line x1="128.507" x2="130.587" y1="43.848" y2="32.047"/>
                        
                <line x1="130.909" x2="132.988" y1="44.272" y2="32.47"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="130.587" x2="129.547" y1="32.047" y2="37.9475"/>
                <line class="hi" stroke="#FF0D0D" x1="130.587" x2="129.547" y1="32.047" y2="37.9475"/>
                <line class="hi" stroke="#FF0D0D" x1="132.988" x2="131.9485" y1="32.47" y2="38.370999999999995"/>
                <line class="hi" stroke="#FF0D0D" x1="132.988" x2="131.9485" y1="32.47" y2="38.370999999999995"/>
            </g>
                  
            <line class="bond" id="mol1bnd4" x1="129.83" x2="118.766" y1="43.367" y2="47.395"/>
                  
            <line class="bond" id="mol1bnd5" x1="114.835" x2="112.865" y1="52.409" y2="63.59"/>
                  
            <g class="bond" id="mol1bnd6">
                        
                <line x1="112.865" x2="98.535" y1="63.59" y2="68.802"/>
                        
                <line x1="112.377" x2="100.692" y1="66.362" y2="70.612"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd7" x1="98.535" x2="95.89" y1="68.802" y2="83.81"/>
                  
            <g class="bond" id="mol1bnd8">
                        
                <line x1="95.89" x2="107.575" y1="83.81" y2="93.607"/>
                        
                <line x1="98.536" x2="108.064" y1="82.847" y2="90.835"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd9" x1="107.575" x2="121.905" y1="93.607" y2="88.395"/>
                  
            <g class="bond" id="mol1bnd10">
                        
                <line x1="121.905" x2="124.55" y1="88.395" y2="73.386"/>
                        
                <line x1="119.748" x2="121.904" y1="86.585" y2="74.35"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd11" x1="112.865" x2="124.55" y1="63.59" y2="73.386"/>
                  
            <line class="bond" id="mol1bnd12" x1="112.496" x2="100.098" y1="46.053" y2="35.652"/>
                  
            <line class="bond" id="mol1bnd13" x1="100.098" x2="92.478" y1="35.652" y2="22.444"/>
                  
            <line class="bond" id="mol1bnd14" x1="92.478" x2="77.238" y1="22.444" y2="22.444"/>
                  
            <line class="bond" id="mol1bnd15" x1="77.238" x2="71.731" y1="22.444" y2="31.989"/>
                  
            <line class="bond" id="mol1bnd16" x1="71.731" x2="77.238" y1="39.314" y2="48.86"/>
                  
            <line class="bond" id="mol1bnd17" x1="77.238" x2="92.478" y1="48.86" y2="48.86"/>
                  
            <line class="bond" id="mol1bnd18" x1="100.098" x2="92.478" y1="35.652" y2="48.86"/>
                  
            <line class="bond" id="mol1bnd19" x1="66.277" x2="54.378" y1="35.652" y2="35.652"/>
                  
            <line class="bond" id="mol1bnd20" x1="54.378" x2="46.758" y1="35.652" y2="22.453"/>
                  
            <line class="bond" id="mol1bnd21" x1="46.758" x2="31.518" y1="22.453" y2="22.453"/>
                  
            <g class="bond" id="mol1bnd22">
                        
                <line x1="23.898" x2="31.518" y1="35.661" y2="22.453"/>
                        
                <line x1="22.49" x2="28.703" y1="33.223" y2="22.453"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd23" x1="23.898" x2="8.658" y1="35.661" y2="35.661"/>
                  
            <g class="bond" id="mol1bnd24">
                        
                <line x1="1.038" x2="8.658" y1="22.453" y2="35.661"/>
                        
                <line x1="3.853" x2="10.066" y1="22.453" y2="33.223"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd25" x1="1.038" x2="8.658" y1="22.453" y2="9.245"/>
                  
            <g class="bond" id="mol1bnd26">
                        
                <line x1="23.898" x2="8.658" y1="9.245" y2="9.245"/>
                        
                <line x1="22.49" x2="10.066" y1="11.684" y2="11.684"/>
                      
            </g>
                  
            <line class="bond" id="mol1bnd27" x1="31.518" x2="23.898" y1="22.453" y2="9.245"/>
                  
            <line class="bond" id="mol1bnd28" x1="100.098" x2="111.774" y1="35.652" y2="25.857"/>
                  
            <g class="bond" id="mol1bnd29">
                        
                <line x1="111.529" x2="122.958" y1="24.47" y2="28.631"/>
                        
                <line x1="110.695" x2="122.124" y1="26.762" y2="30.923"/>
                      
                <line class="hi" stroke="#FF0D0D" x1="122.958" x2="117.2435" y1="28.631" y2="26.5505"/>
                <line class="hi" stroke="#FF0D0D" x1="122.124" x2="116.4095" y1="30.923" y2="28.8425"/>
            </g>
                  
            <line class="bond" id="mol1bnd30" x1="111.774" x2="109.816" y1="25.857" y2="14.748"/>
                  
            <line class="bond" id="mol1bnd31" x1="112.09" x2="120.804" y1="8.364" y2="1.053"/>
                  
            <path class="atom" d="M134.734 28.355q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.309q.25 -.566 .756 -.882q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.5 .31 .756 .876q.256 .565 .256 1.327zM130.871 28.355q-.0 .923 .387 1.459q.393 .529 1.22 .529q.839 .0 1.22 -.529q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.452q-.381 -.524 -1.208 -.524q-.834 -.0 -1.226 .524q-.393 .523 -.393 1.452z" id="mol1atm4" stroke="none"/>
                  
            <path class="atom" d="M117.451 51.03h-.721l-2.619 -4.066h-.03q.012 .239 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.715l2.607 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.221 -.024 -.477q-.006 -.261 -.006 -.482v-2.768h.578v4.899z" fill="#3050F8" id="mol1atm5" stroke="none"/>
                  
            <path class="atom" d="M71.559 38.101h-.72l-2.62 -4.066h-.03q.012 .238 .03 .596q.024 .357 .024 .732v2.738h-.566v-4.899h.715l2.607 4.054h.03q-.006 -.107 -.018 -.327q-.012 -.221 -.024 -.477q-.006 -.262 -.006 -.482v-2.768h.578v4.899z" fill="#3050F8" id="mol1atm15" stroke="none"/>
                  
            <path class="atom" d="M128.353 31.068q.0 .756 -.256 1.327q-.256 .566 -.756 .881q-.5 .316 -1.244 .316q-.756 -.0 -1.262 -.316q-.506 -.315 -.756 -.887q-.244 -.571 -.244 -1.333q-.0 -.75 .244 -1.31q.25 -.565 .756 -.881q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.5 .31 .756 .875q.256 .566 .256 1.328zM124.49 31.068q-.0 .922 .387 1.458q.393 .53 1.22 .53q.839 .0 1.22 -.53q.387 -.536 .387 -1.458q.0 -.929 -.387 -1.453q-.381 -.524 -1.208 -.524q-.834 .0 -1.226 .524q-.393 .524 -.393 1.453z" id="mol1atm27" stroke="none"/>
                  
            <path class="atom" d="M111.388 10.845q.0 .756 -.256 1.328q-.256 .565 -.756 .881q-.5 .315 -1.244 .315q-.756 .0 -1.262 -.315q-.506 -.316 -.756 -.887q-.244 -.572 -.244 -1.334q-.0 -.75 .244 -1.31q.25 -.565 .756 -.881q.506 -.315 1.274 -.315q.732 -.0 1.232 .315q.5 .31 .756 .875q.256 .566 .256 1.328zM107.525 10.845q-.0 .923 .386 1.459q.393 .529 1.221 .529q.839 .0 1.22 -.529q.387 -.536 .387 -1.459q.0 -.929 -.387 -1.453q-.381 -.523 -1.208 -.523q-.834 -.0 -1.227 .523q-.392 .524 -.392 1.453z" id="mol1atm28" stroke="none"/>
                
            <line class="hi" id="mol1bnd4" stroke="#3050F8" x1="118.766" x2="124.298" y1="47.395" y2="45.381"/>
            <line class="hi" id="mol1bnd5" stroke="#3050F8" x1="114.835" x2="113.85" y1="52.409" y2="57.9995"/>
            <line class="hi" id="mol1bnd12" stroke="#3050F8" x1="112.496" x2="106.297" y1="46.053" y2="40.8525"/>
            <line class="hi" id="mol1bnd15" stroke="#3050F8" x1="71.731" x2="74.4845" y1="31.989" y2="27.2165"/>
            <line class="hi" id="mol1bnd16" stroke="#3050F8" x1="71.731" x2="74.4845" y1="39.314" y2="44.087"/>
            <line class="hi" id="mol1bnd19" stroke="#3050F8" x1="66.277" x2="60.3275" y1="35.652" y2="35.652"/>
            <line class="hi" id="mol1bnd30" stroke="#FF0D0D" x1="109.816" x2="110.795" y1="14.748" y2="20.3025"/>
            <line class="hi" id="mol1bnd31" stroke="#FF0D0D" x1="112.09" x2="116.447" y1="8.364" y2="4.708500000000001"/>
        </g>
          
    </g>
    
</svg>
","Therapeutic Uses":"Analgesics, Opioid","Title":"Carfentanyl","UNII":"LA9DTA2L8F","Wikidata":"Q423386","XLogP":3.8}